前列腺癌碳离子放疗后急性泌尿毒性的NTCP模型
该回顾性研究纳入154例前列腺腺癌患者,基于剂量学参数和临床因素构建LKB与多变量NTCP模型预测碳离子放疗后急性泌尿毒性。59例(38.3%)发生AUT,LKB模型和多变量模型对AUT G1&2及G2均显示出一定预测能力,降低膀胱高剂量体积可能减少AUT发生。
要点
- 154例前列腺癌CIRT患者中59例(38.3%)发生急性泌尿毒性。
- LKB模型预测膀胱AUT G1&2的NTCP为37.0%(AUC 0.71)。
- 降低膀胱高剂量体积可能减少急性泌尿毒性发生。
核心结论
- LKB模型成功预测了AUT两个等级及尿急的NTCP率,多变量模型对两个等级及夜尿症预测良好。
研究设计与样本
- 回顾性分析154例前列腺腺癌患者,AUT按CTCAE 4.03分级,基于剂量学参数和/或临床因素构建LKB和多变量NTCP模型。
主要发现
- 59例(38.3%)患者发生AUT。
- LKB模型中膀胱AUT G1&2的EUD为62.0 GyE(V61.5>1.7%条件下),预测NTCP率37.0%(AUC 0.71)。
- LKB模型中膀胱AUT G2的EUD为61.2 GyE(最大剂量>63.0 GyE条件下),预测NTCP率15.6%(AUC 0.65)。
- 多变量模型预测AUT G1&2的NTCP率为37.1%(AUC 0.70),与V61相关;预测G2的NTCP率为20.2%(AUC 0.64),与V65相关。
- 夜尿症在G1&2中与膀胱体积和最大剂量相关,在G2中与患者年龄和膀胱最大剂量相关;其他可预测终点与V≥61相关。
关键数值与推荐
- LKB模型膀胱AUT G1&2:EUD 62.0 GyE(V61.5>1.7%),预测NTCP率37.0%(AUC 0.71)。
- LKB模型膀胱AUT G2:EUD 61.2 GyE(最大剂量>63.0 GyE),预测NTCP率15.6%(AUC 0.65)。
- 多变量模型AUT G1&2:预测NTCP率37.1%(AUC 0.70),与V61相关;AUT G2:预测NTCP率20.2%(AUC 0.64),与V65相关。
临床怎么用
- 可采用LKB或多变量NTCP模型预测前列腺癌CIRT后急性泌尿毒性风险。
- 降低膀胱高剂量照射体积可能减少急性泌尿毒性发生率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To estimate the Lyman Kutcher Burman (LKB) and multivariate NTCP models predicting the AUT of prostate cancer treated with CIRT. MATERIALS AND METHODS: A cohort of 154 prostate adenocarcinoma patients were retrospectively analyzed. The AUT levels were graded according to CTCAE 4.03. Based on dosimetric parameters and/or clinical factors, a set of variables with best-fit values determined in the two models was validated by the area under the receiver operating characteristic curve (AUC) and used to correlate the predicted and observed NTCP rates for both levels and related endpoints. RESULT: 59 (38.3%) patients experienced AUT. For LKB model, the equivalent uniform doses (EUDs) were calculated to be 62.0 GyE (following V61.5 > 1.7%) and 61.2 GyE (following maximum dose > 63.0 GyE) with predicted NTCP rates of 37.0% (AUC: 0.71) and 15.6% (AUC: 0.65) for AUT G1&2 and G2 of bladder. While for the multivariate model, the predicted NTCP rates was 37.1% (AUC: 0.70) and 20.2% (AUC: 0.64) for AUT G1&2 and G2, associated with V61 and V65, respectively. Nocturia was associated with bladder volume and maximum dose for G1&2, with patient's age and maximum bladder dose for G2. Other predictable endpoints were associated with V≥61. The predicted NTCPs agree with the observed complication rates for bladder and its wall. CONCLUSIONS: The LKB model successfully predicted the NTCP rates of both AUT levels and urgency urination. The multivariate model predicted well on both levels and nocturia. Decreasing high bladder dose volume may reduce the incidence of AUT.
引用
- Li Y, Li P, Hsi W, et al. Normal tissue complication probability (NTCP) models of acute urinary toxicity (AUT) following carbon ion radiotherapy (CIRT) for prostate cancer. Radiother Oncol. 2020. PMID: 33309999. doi:10.1016/j.radonc.2020.12.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。